Pete Rose on steroids and the Hall of Fame

37 Comments

The San Francisco Chronicle posted a quick interview with Pete Rose on Thursday, in parge part to get his reaction to the Buster Posey collision and injury (click on the link if you want to read about that).  Rose, though, was also asked about steroids and had a pretty good take:

I’m not the one who is going to sit here and judge (Barry) Bonds, or judge Rafael (Palmeiro). All I know is they put up numbers. I’m going to tell you right now, though, Barry Bonds is one of the best hitters in the history of baseball. (Alex Rodriguez) is one of the better hitters in the history of baseball.

I’m not sure Mark McGwire was a Hall of Famer to begin with. I was a little surprised Raffy (Palmeiro) didn’t get more votes than he did. I’m going to hold my judgment on that until I get a real legitimate Hall of Famer like a Bonds or a (Roger) Clemens, and see what kind of response they get on the ballot. You know A-Rod has it made because he won’t be on the ballot until 2023. People will forget by then.

Pretty sensible if you ask me.  The only thing I disagree with is the idea that McGwire isn’t a Hall of Famer to begin with.  It sounds like Rose is saying McGwire doesn’t have Hall of Fame numbers (which he does), not that McGwire only has HoF numbers because of steroids (which is a more legitimate argument). I might be reading it wrong, though.

Noah Syndergaard: ‘I feel like I’m going to bet (on) myself in free agency’

Mike Stobe/Getty Images
5 Comments

Yankees starter Luis Severino and Phillies starter Aaron Nola both signed contract extensions within the last week. Severino agreed to a four-year, $40 million contract with a 2023 club option. Nola inked a four-year, $45 million deal with a 2023 club option.

While the deals both represented significant raises and longer-term financial security for the right-handed duo, some feel like the players are selling themselves short. It has become a more common practice for players to agree to these types of deals in part due to how stagnant free agency has become. Get the money while you can.

Mets starter Noah Syndergaard is in a similar situation as Severino and Nola were. He and the Mets avoided arbitration last month, agreeing on a $6 million salary for the 2019 season. He has two more years of arbitration eligibility left. A contract extension with the Mets would presumably cover both of those years plus two or three years of what would be free agent years. As Tim Britton of The Athletic reports, however, Syndergaard plans to test free agency when the time comes.

Syndergaard said, “I trust my ability and the talent that I have. So I feel like I’m going to bet (on) myself in free agency and not do what they did. But if it’s fair for both sides and they approach me on it, then maybe we can talk.” He clarified that he would be open to a conversation about an extension, but the Mets thus far haven’t approached him about it. In his words, “There’s been no traction.”

Syndergaard, 26, has been one of baseball’s better starters since debuting in 2015. He owns a career 2.93 ERA with 573 strikeouts and 116 walks in 518 1/3 innings. Among pitchers to have logged at least 400 innings since 2015 and post a lower ERA are Clayton Kershaw (2.22), Jacob deGrom (2.66) and Max Scherzer (2.71). Syndergaard made only seven starts in 2017 yet still ranks seventh among pitchers in total strikeouts since 2015.

If Sydergaard doesn’t end up signing an extension, he will be entering free agency after the 2021 season. The collective bargaining agreement expires in December 2021 and a new one will likely be agreed upon around that time. Syndergaard will hopefully have better prospects entering free agency then than players do now.